About
SMART Biotech offers Stimmunology, a technology platform designed to enable the detection of various infectious diseases, such as HIV, HCV, and others, within days of infection by processing and enhancing blood samples prior to testing. The companys SMARTube is a pre-analytic device based on the Stimmunology technology which enables the detection of various infections using currently available antibody tests (e.g. EIA, Rapid test, Western Blot, etc.). Enhancing the antibody production in a blood sample using the SMARTube allows users to close the serological window between infection and possible detection independent of the specific serological timeframe or the presence of virus in the blood. The SMARTube reduces the number of both false positive and false negative results. It can also be used as an effective tool to distinguish between recent and non-recent infections, as well as to report either spontaneous or drug-elicited viral clearance shortly after occurence.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary technology offered by SMART Biotech?
- SMART Biotech offers Stimmunology, a technology platform designed for the early detection of infectious diseases like HIV and HCV.
- What is the function of SMART Biotech's SMARTube product?
- The SMARTube is a pre-analytic device based on Stimmunology technology that enhances antibody production in blood samples, allowing for earlier detection of infections using existing antibody tests and reducing false positive/negative results.
- When was SMART Biotech founded?
- SMART Biotech was founded in January 2004.
- What is the current status of SMART Biotech?
- According to startupim data, SMART Biotech is currently inactive as of May 2015.
- Where is SMART Biotech headquartered?
- SMART Biotech is headquartered in Rishon LeTsiyon, Center District, Israel.
- How many employees does SMART Biotech have?
- SMART Biotech has 2 employees.
- What is a key benefit of SMART Biotech's technology for disease detection?
- SMART Biotech's technology aims to close the serological window between infection and possible detection, independent of the specific serological timeframe.
- Which market does SMART Biotech primarily target geographically?
- SMART Biotech primarily targets the United States market.
- Who are the founders of SMART Biotech?
- The founders of SMART Biotech are Yisrael Serok and Tamar Jehuda-Cohen.